1696 Nucleic Acids Research, 2010, Vol. 38, No. 5 REFERENCES 1. Bolinger,C. and Boris-Lawrie,K. (2009) Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome. Retrovirology, 6, 8. 2. Hartman,T.R., Qian,S., Bolinger,C., Fernandez,S., Schoenberg,D.R. and Boris-Lawrie,K. (2006) RNA helicase A is necessary for translation of selected messenger RNAs. Nat. Struct. Mol. Biol., 13, 509–516. 3. Butsch,M., Hull,S., Wang,Y., Roberts,T.M. and Boris-Lawrie,K. (1999) The 50 RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeﬁciency virus Rev/RRE-independent Gag production. J. Virol., 73, 4847–4855. 4. Hull,S. and Boris-Lawrie,K. (2002) RU5 of Mason-Pﬁzer monkey virus 50 long terminal repeat enhances cytoplasmic expression of human immunodeﬁciency virus type 1 gag-pol and nonviral reporter RNA. J. Virol., 76, 10211–10218. 5. Bolinger,C., Yilmaz,A., Hartman,T.R., Kovacic,M.B., Fernandez,S., Ye,J., Forget,M., Green,P.L. and Boris-Lawrie,K. (2007) RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1. Nucleic Acids Res., 35, 2629–2642. 6. Russell,R.A., Zeng,Y., Erlwein,O., Cullen,B.R. and McClure,M.O. (2001) The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression. J. Virol., 75, 6817–6824. 7. Roberts,T.M. and Boris-Lawrie,K. (2003) Primary sequence and secondary structure motifs in spleen necrosis virus RU5 confer translational utilization of unspliced human immunodeﬁciency virus type 1 reporter RNA. J. Virol., 77, 11973–11984. 8. Bushman,F.D., Malani,N., Fernandes,J., D’Orso,I., Cagney,G., Diamond,T.L., Zhou,H., Hazuda,D.J., Espeseth,A.S., Konig,R. et al. (2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog., 5, e1000437. 9. Fujii,R., Okamoto,M., Aratani,S., Oishi,T., Ohshima,T., Taira,K., Baba,M., Fukamizu,A. and Nakajima,T. (2001) A role of RNA Helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeﬁciency virus type 1. J. Biol. Chem., 276, 5445–5451. 10. Li,J., Tang,H., Mullen,T.M., Westberg,C., Reddy,T.R., Rose,D.W. and Wong-Staal,F. (1999) A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc. Natl Acad. Sci. USA, 96, 709–714. 11. Nakajima,T., Uchida,C., Anderson,S.F., Lee,C.G., Hurwitz,J., Parvin,J.D. and Montminy,M. (1997) RNA helicase A mediates association of CBP with RNA polymerase II. Cell, 90, 1107–1112. 12. Roy,B.B., Hu,J., Guo,X., Russell,R.S., Guo,F., Kleiman,L. and Liang,C. (2006) Association of RNA helicase a with human immunodeﬁciency virus type 1 particles. J. Biol. Chem., 281, 12625–12635. 13. Derdeyn,C.A., Decker,J.M., Sfakianos,J.N., Wu,X., O’Brien,W.A., Ratner,L., Kappes,J.C., Shaw,G.M. and Hunter,E. (2000) Sensitivity of human immunodeﬁciency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor speciﬁcity deﬁned by the V3 loop of gp120. J. Virol., 74, 8358–8367. 14. Platt,E.J., Wehrly,K., Kuhmann,S.E., Chesebro,B. and Kabat,D. (1998) Eﬀects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeﬁciency virus type 1. J. Virol., 72, 2855–2864. 15. Takeuchi,Y., McClure,M.O. and Pizzato,M. (2008) Identiﬁcation of gammaretroviruses constitutively released from cell lines used for human immunodeﬁciency virus research. J. Virol., 82, 12585–12588. 16. Wei,X., Decker,J.M., Liu,H., Zhang,Z., Arani,R.B., Kilby,J.M., Saag,M.S., Wu,X., Shaw,G.M. and Kappes,J.C. (2002) Emergence of resistant human immunodeﬁciency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother., 46, 1896–1905. 17. Xie,L., Yamamoto,B., Haoudi,A., Semmes,O.J. and Green,P.L. (2006) PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo. Blood, 107, 1980–1988. 18. Hull,S. and Boris-Lawrie,K. (2003) Analysis of synergy between divergent simple retrovirus posttranscriptional control elements. Virology, 317, 146–154. 19. Connor,R.I., Chen,B.K., Choe,S. and Landau,N.R. (1995) Vpr is required for eﬃcient replication of human immunodeﬁciency virus type-1 in mononuclear phagocytes. Virology, 206, 935–944. 20. Pelletier,J. and Sonenberg,N. (1985) Insertion mutagenesis to increase secondary structure within the 50 noncoding region of a eukaryotic mRNA reduces translational eﬃciency. Cell, 40, 515–526. 21. Parkin,N.T., Cohen,E.A., Darveau,A., Rosen,C., Haseltine,W. and Sonenberg,N. (1988) Mutational analysis of the 50 non-coding region of human immunodeﬁciency virus type 1: eﬀects of secondary structure on translation. EMBO J., 7, 2831–2837. 22. Fierro-Monti,I. and Mathews,M.B. (2000) Proteins binding to duplexed RNA: one motif, multiple functions. Trends Biochem. Sci, 25, 241–246. 23. Cen,S., Khorchid,A., Javanbakht,H., Gabor,J., Stello,T., Shiba,K., Musier-Forsyth,K. and Kleiman,L. (2001) Incorporation of lysyl-tRNA synthetase into human immunodeﬁciency virus type 1. J. Virol., 75, 5043–5048. 24. Beliakova-Bethell,N., Beckham,C., Giddings,T.H. Jr, Winey,M., Parker,R. and Sandmeyer,S. (2006) Virus-like particles of the Ty3 retrotransposon assemble in association with P-body components. RNA, 12, 94–101. 25. Irwin,B., Aye,M., Baldi,P., Beliakova-Bethell,N., Cheng,H., Dou,Y., Liou,W. and Sandmeyer,S. (2005) Retroviruses and yeast retrotransposons use overlapping sets of host genes. Genome Res., 15, 641–654. 26. Butsch,M. and Boris-Lawrie,K. (2000) Translation is not required to generate virion precursor RNA in human immunodeﬁciency virus type 1-infected T cells. J. Virol., 74, 11531–11537. 27. Yedavalli,V.S., Neuveut,C., Chi,Y.H., Kleiman,L. and Jeang,K.T. (2004) Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell, 119, 381–392. 28. Lindtner,S., Zolotukhin,A.S., Uranishi,H., Bear,J., Kulkarni,V., Smulevitch,S., Samiotaki,M., Panayotou,G., Felber,B.K. and Pavlakis,G.N. (2006) RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway. J. Biol. Chem., 281, 36915–36928. 29. Zolotukhin,A.S., Uranishi,H., Lindtner,S., Bear,J., Pavlakis,G.N. and Felber,B.K. (2009) Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA. Nucleic Acids Res., [Epub 28 September, 2009] PMID: 19786495 30. Ma,J., Rong,L., Zhou,Y., Roy,B.B., Lu,J., Abrahamyan,L., Mouland,A.J., Pan,Q. and Liang,C. (2008) The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeﬁciency virus type 1 RNA. Virology, 375, 253–264. 31. Butsch,M. and Boris-Lawrie,K. (2002) Destiny of unspliced retroviral RNA: ribosome and/or virion? J. Virol., 76, 3089–3094. 32. Sadler,A.J., Latchoumanin,O., Hawkes,D., Mak,J. and Williams,B.R. (2009) An antiviral response directed by PKR phosphorylation of the RNA helicase A. PLoS Pathog., 5, e1000311. 33. Attal,J., Theron,M.C., Kann,G., Bolifraud,P., Puissant,C. and Houdebine,L.M. (2000) The stimulation of gene expression by the R region from HTLV-1 and BLV. J. Biotechnol., 77, 179–189. 34. Attal,J., Theron,M.C., Taboit,F., Cajero-Juarez,M., Kann,G., Bolifraud,P. and Houdebine,L.M. (1996) The RU5 (‘R’) region from human leukaemia viruses (HTLV-1) contains an internal ribosome entry site (IRES)-like sequence. FEBS Lett., 392, 220–224. 35. Yilmaz,A., Fernandez,S., Lairmore,M.D. and Boris-Lawrie,K. (2006) Coordinate enhancement of transgene transcription and translation in a lentiviral vector. Retrovirology, 3, 13. 36. Roberts,T.M. and Boris-Lawrie,K. (2000) The 50 RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNA. J. Virol., 74, 8111–8118.